Novo Nordisk's pricing tactics inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of value gouging, stating the stark distinction between U.S. price ranges and people in Europe and copyright. But Rybelsus and copyright do have some